The FDA is launching a pilot program using AI and cloud computing to monitor clinical trials in real time. The agency expects the initiative to accelerate drug approval timelines.
The FDA's new monitoring system leverages artificial intelligence and cloud infrastructure to track clinical trial data as it emerges, rather than relying on traditional post-trial analysis.
Real-time oversight could identify safety issues and efficacy signals earlier in the trial process, potentially shortening the overall approval timeline for new drugs. The pilot program represents a significant operational shift for the agency.
This development comes as the FDA rebuilds its workforce following staffing reductions tied to DOGE (Department of Government Efficiency) initiatives. The agency is positioning automation and advanced technologies as force multipliers to maintain oversight capabilities amid staffing constraints.
Cloud-based systems and AI analytics allow remote monitoring of distributed trial sites and participant data, reducing the manual review burden on FDA staff. The pilot will test whether these tools deliver on their promised efficiency gains while maintaining regulatory rigor.
The program underscores a broader trend across federal agencies toward adopting AI and cloud solutions to modernize operations and improve service delivery.
Z.ai has confirmed that Ox Alpha, a previously undisclosed language model, is part of its GLM-series lineup. The company plans to release the model's weights publicly.
Artificial intelligence is enabling Asian businesses to expand internationally at record speeds, according to Stripe's managing director for Southeast Asia, Greater China and South Korea.
Anthropic has released the Model Hardware Standard, a framework enabling AI agents to control physical systems like microscopes, robot arms, and quantum computing hardware. The initiative aims to standardize how AI interacts with devices while addressing emerging safety risks.
Google has launched 'Expert Intelligence,' a new feature in Gemini Notebook that pulls content from Google Play Books, allowing users to ask questions and generate AI-assisted materials based on book contents.